These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 8134661
1. Immunization of dogs with Q fever vaccines: comparison of phase I, II and phase I CMR Coxiella burnetii vaccines. Williams JC, Peacock MG, Race RE. Rev Elev Med Vet Pays Trop; 1993; 46(1-2):87-94. PubMed ID: 8134661 [Abstract] [Full Text] [Related]
4. A refined guinea pig model for evaluating delayed-type hypersensitivity reactions caused by Q fever vaccines. Ruble DL, Elliott JJ, Waag DM, Jaax GP. Lab Anim Sci; 1994 Dec; 44(6):608-12. PubMed ID: 7898035 [Abstract] [Full Text] [Related]
5. Comparison of Q fever cellular and chloroform-methanol residue vaccines as skin test antigens in the sensitized guinea pig. Elliott JJ, Ruble DL, Zaucha GM, Jaax GP, Waag DM. Acta Virol; 1998 Jun; 42(3):147-55. PubMed ID: 9842444 [Abstract] [Full Text] [Related]
6. [Experience in vaccinating farm animals for preventing Q fever in humans]. Lisák V. Tr Inst Im Pastera; 1989 Jun; 66():143-53, 174. PubMed ID: 2485300 [Abstract] [Full Text] [Related]
7. Protective immunity induced by 67 K outer membrane protein of phase I Coxiella burnetii in mice and guinea pigs. Zhang YX, Zhi N, Yu SR, Li QJ, Yu GQ, Zhang X. Acta Virol; 1994 Dec; 38(6):327-32. PubMed ID: 7793356 [Abstract] [Full Text] [Related]
9. Biological properties of chloroform/methanol extracts of Coxiella Burnetii. Tokarevich NK, Daiter AB, Polotsky YE, Lukácová M, Kazár J, Kartseva NA, Kuzina VA, Efremov VE, Belov AG. Acta Virol; 1993 Feb; 37(1):29-40. PubMed ID: 8105650 [Abstract] [Full Text] [Related]
10. Vaccines against coxiellosis and Q fever. Development of a chloroform:methanol residue subunit of phase I Coxiella burnetti for the immunization of animals. Williams JC, Peacock MG, Waag DM, Kent G, England MJ, Nelson G, Stephenson EH. Ann N Y Acad Sci; 1992 Jun 16; 653():88-111. PubMed ID: 1626897 [Abstract] [Full Text] [Related]
11. Comparative efficacy of a Coxiella burnetii chloroform:methanol residue (CMR) vaccine and a licensed cellular vaccine (Q-Vax) in rodents challenged by aerosol. Waag DM, England MJ, Pitt ML. Vaccine; 1997 Nov 16; 15(16):1779-83. PubMed ID: 9364683 [Abstract] [Full Text] [Related]
12. Immunogenicity of Coxiella burnetii whole cells and their outer membrane components. Gajdosová E, Kovácová E, Toman R, Skultéty L, Lukácová M, Kazár J. Acta Virol; 1994 Dec 16; 38(6):339-44. PubMed ID: 7793358 [Abstract] [Full Text] [Related]
14. Vaccines against Coxiella infection. Zhang G, Samuel JE. Expert Rev Vaccines; 2004 Oct 16; 3(5):577-84. PubMed ID: 15485337 [Abstract] [Full Text] [Related]
15. Antigenicity of chloroform-methanol-treated Coxiella burnetii preparations. Kazár J, Schramek S, Lisák V, Brezina R. Acta Virol; 1987 Mar 16; 31(2):158-67. PubMed ID: 2886025 [Abstract] [Full Text] [Related]
16. Safety and immunogenicity in human volunteers of a chloroform-methanol residue vaccine for Q fever. Fries LF, Waag DM, Williams JC. Infect Immun; 1993 Apr 16; 61(4):1251-8. PubMed ID: 8454328 [Abstract] [Full Text] [Related]
17. Q fever vaccination of sheep: challenge of immunity in ewes. Brooks DL, Ermel RW, Franti CE, Ruppanner R, Behymer DE, Williams JC, Stephenson EH. Am J Vet Res; 1986 Jun 16; 47(6):1235-8. PubMed ID: 3729123 [Abstract] [Full Text] [Related]
18. Comparative efficacy and immunogenicity of Q fever chloroform:methanol residue (CMR) and phase I cellular (Q-Vax) vaccines in cynomolgus monkeys challenged by aerosol. Waag DM, England MJ, Tammariello RF, Byrne WR, Gibbs P, Banfield CM, Pitt ML. Vaccine; 2002 Jun 07; 20(19-20):2623-34. PubMed ID: 12057622 [Abstract] [Full Text] [Related]